Moderna wins EU approval for updated COVID-19 vaccine - PharmaTimes Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season

#vaccines #Moderna #COVID19vaccine #Spikevax #LP81variant #marketingauthorisation #updatedCOVID19vaccine #SARSCoV2variantLP81 #EuropeanMedicinesAgency #EMA #20252026vaccinationseason #eligiblepopulations #globalhealthauthorities #ModernaCOVID19vaccines
pharmatimes.com/news/moderna...